Cell Biology and Toxicology

, Volume 12, Issue 4–6, pp 341–344 | Cite as

Description of an in vitro angiogenesis model designed to test antiangiogenic molecules

  • B. Vailhé
  • X. Ronot
  • M. Lecomte
  • N. Wiernsperger
  • L. Tranqui
Selected posters


Angiogenesis is involved in numerous pathologies. Studies with in vitro models allow the description and analysis of the different steps involved in this process under defined culture conditions. We describe a controllable and reproducible in vitro model. We assessed the usefulness of this model with two different cell lines: human umbilical vein endothelial cells and bovine retinal endothelial cells. These cells reorganize themselves and change their phenotypes within 24 h after seeding under our culture conditions (low human serum percentage, defined cell density, fibrin matrix) to form ‘capillary-like structures’ (CLS) in vitro. We showed that, depending on the cell line used, the fibrinolytic activity of the cells was a determining factor which could induce or prevent the formation of the CLS. Inhibitors of angiogenesis can be tested using such a model.

Key words

endothelial cells fibrin in vitro angiogenesis 



human umbilical vein endothelial cells


bovine retinal endothelial cells


capillary-like structure


human serum


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Engvall E, Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977;20:1–5.Google Scholar
  2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1995;1(1):27–31.Google Scholar
  3. Ingber DE, Folkman J. How does extracellular matrix control capillary morphogenesis? Cell. 1989;58:803–5.Google Scholar
  4. Jaffé EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745–56.Google Scholar
  5. Keckwick RA, McKay ME, Nance MH, Record BR. The purification of human fibrinogen. Biochem J. 1955;60:671–83.Google Scholar
  6. Kishimoto T, Oguri T, Tada M. Methylmercury-injury effect on tube formation by cultured human vascular endothelial cells. Cell Biol Toxicol. 1995;11:29–36.Google Scholar
  7. Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M. Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem. 1996; 66(5):[in press].Google Scholar
  8. Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem. 1979;254:5357–63.Google Scholar
  9. Montesano R, Vassali JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA. 1986;83:7297–301.Google Scholar
  10. Pepper MS, Belin D, Montesano R, Orci L, Vassali JD. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol. 1990; 111:743–55.Google Scholar
  11. Pepper MS, Vassali JD, Orci L, Montesano R. Angiogenesis in vitro: cytokines interactions and balanced extracellular proteolysis. In: Maragoudakis ME et al., eds. Angiogenesis: molecular biology, clinical aspects. New York: Plenum Press; 1994:149–70.Google Scholar
  12. Vernon RB, Sage EH. Between molecules and morphology. Extracellular matrix and creation of vascular form. Am J Pathol. 1995;147(4):873–83.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • B. Vailhé
    • 1
  • X. Ronot
    • 2
    • 3
  • M. Lecomte
    • 4
  • N. Wiernsperger
    • 4
  • L. Tranqui
    • 1
  1. 1.Laboratoire de Bioénergétique Fondamentale et AppliquéeUniversité Joseph FourierGrenoble Cédex
  2. 2.Laboratoire Dynamique de l'Organisation des Génomes, Institut AlbertBonniotUniversité Joseph FourierLa Tronche Cédex
  3. 3.Laboratoire de Neurobiologie du DéveloppementE.P.H.E.Montpellier Cédex
  4. 4.Lipha-INSERM U352INSA LyonVilleurbanneFrance

Personalised recommendations